Page 224 - ASHG 2012 Annual Meeting Program Guide

POSTER SESSIONS
213
POSTER SESSIONS
W=Wednesday authors will present; T=Thursday authors will present; F=Friday authors will present
2480
F The effects of inherited deletions on
neurocognition in Canadian children with 22q11.2
deletion syndrome.
E. Chow, A. Ho, D. Young, S.
Langlois, C. Cytrabaum, A. Rideout, S. Dyack.
2481
W Brain-derived neurotrophic factor (
BDNF
)
Val66Met and adulthood chronic stress interact to
affect depressive symptoms.
R. Jiang, B. H. Brummett,
M. A. Babyak, I. C. Siegler, R. B. Williams.
2482
T miRNA expression in the prefrontal cortex of
suicide completers.
J. P. Lopez, R. Lim, B. Labonte, C.
Cruceanu, J. P. Yang, V. Yerko, C. Ernst, N. Mechawar, P.
Pavlidis, G. Turecki.
2483
F Distinct gene expression and DNA methylation
perturbations in PTSD with severe child abuse versus
no PTSD with no child abuse.
D. Mehta, T. Klengel, K.
N. Conneely, A. K. Smith, A. Altmann, M. Rex-Haffner, A.
Loeschner, M. Gonik, K. B. Mercer, B. Bradley, B. Müller-
Myshok, K. J. Ressler, E. B. Binder.
2484
W Frequency of polymorphisms of the alcohol
dehydrogenase enzyme (ADH1B and ADH1C) and
aldehyde dehydrogenase enzyme (ALDH) in the
Brazilian population.
G. P. M. Antonialli, B. Coprerski, R.
M. Minillo, M. P. Migliavacca, D. Brunoni, A. B. A. Perez.
2485
T Serotonin transporter (SLC6A4) and receptor
(5-
HT2A) gene polymorphisms in healthy Brazilian
individuals with diverse ethnic backgrounds.
B.
Coprerski, M. P. Micliavacca, A. B. A. Perez, A. P. P. Costa,
D. Brunoni.
2486
F Regulatory effects of genes associated with
schizophrenia.
N. Eckart, R. Wang, J. McGrath, P.
Wolyniec, M. Zeledòn, M. Szymanski, A. Pulver, D. Valle,
D. Avramopoulos.
2487
W Genome-wide association study of 32,143
individuals reveals several novel associations in
schizophrenia.
C. O’Dushlaine, S. Ripke, J. Moran, K.
Chambert, P. Sklar, S. Purcell, C. Hultman, S. McCarroll,
P. Sullivan, Swedish Schizophrenia Consortium.
2488
T Genome-wide association study reveals genes
influencing the rate of cognitive decline among
persons with Alzheimer’s disease are distinct from
those associated with disease risk.
R. Sherva, Y.
Tripodis, D. Bennett, L. A. Chibnik, P. K. Crane, P. De
Jager, L. B. Farrer, J. Shulman, R. C. Green.
2489
F Genome-wide scan for copy number variation
association with age at onset of Alzheimer’s disease.
K. Szigeti, D. Lal, Y. Li, R. Doody, K. Wilhelmsen, L.
Yan, S. Liu, C. Ma, Texas Alzheimer Research and Care
Consortium.
2490
W Utilizing eQTL networks to identify genes
relevant to autism in the 16p11.2 region.
Y. Cheng,
W. Lauren.
2467
T Functional testing of schizophrenia associated
variants in
NOS1AP
.
C. T. Ramirez, N. Wratten, Y. Huang,
A. Dulencin, J. Millonig, V. J. Vieland, A. S. Bassett, L. M.
Brzustowicz.
2468
F
MIR137
,
a candidate gene for schizophrenia:
identification of targets and downstream effects.
A. L. Collins, R. J. Bloom, Y. Kim, P. F. Sullivan.
2469
W Schizophrenia mir137 risk genotype is
associated with DLPFC hyperactivation.
T. G. M. van
Erp, I. Guella, M. P. Vawter, F. Torri, J. Fallon, F. Macciardi,
S. G. Potkin.
2470
T A loss-of-function variant in the human histidyl-
tRNA synthetase (
HARS
)
gene is neurotoxic in vivo.
A.
Antonellis, A. Vester, G. Velez-Ruiz, H. M. McLaughlin, J.
R. Lupski, K. Talbot, J. M. Vance, S. Zuchner, R. H. Roda,
K. H. Fischbeck, L. G. Biesecker, G. Nicholson, A. A. Beg,
NISC Comparative Sequencing Program, NIH.
2471
F Neuronal expression of FIG4 and
neurodegeneration.
G. M. Lenk, C. J. Ferguson,
M. H. Meisler.
2472
W Global mapping of FUS-binding sites and global
profiling of FUS-mediated RNA metabolisms in the
mouse brain.
K. Ohno, A. Masuda, S. Ishigaki, Y. Fujioka,
Y. Iguchi, M. Katsuno, A. Shibata, F. Urano, G. Sobue.
2473
T
Sortilin-related receptor 1
is associated with
cognitive impairment in Filipinos.
C. R. Casingal, M. L.
G. Daroy, C. A. Mapua, D. J. A. Florendo, J. C. Dominguez,
St. Luke’s Dementia Study Group.
2474
F Identifying neuropsychological and cognitive
endophenotypes of schizophrenia-associated
exonic variants of
NPAS3
and
COMT
.
L. M. Luoma,
G. Macintyre, F. B. Berry, D. LaFreniere, S. Purser, A.
Beierbach, P. Tibbo, D. W. Cox, S. Purdon.
2475
W Production of IL-6 is altered in primary human
macrophages carrying 255Adel
PARK2
gene variation.
R.
H. M. Sindeaux, A. C. Senegaglia, R. P. Munhoz, H. A. Teive,
S. Raskin, M. M. A. Stefani, M. T. Mira, V. S. Sotomaior.
2476
T Broadening the role of FMRP targets across
autism spectrum disorders.
J. Steinberg, C. Webber.
2477
F Expanded hexanucleotide GGGGCC repeat
RNA associated with ALS/FTD is sufficient to cause
neurodegeneration.
Z. Xu, M. Poidevin, H. Li, T. Wingo,
P. Jin.
2478
W An integrated and systematic approach to
autism pathway analysis.
Z. Lin, S. J. Sanders, J. K.
Lowe, D. H. Geschwind, M. State, H. Zhao.
2479
T RNA sequencing in iPSC-derived neurons
identifies gene expression changes associated with
22
q11.2 microdeletion syndrome.
Y. Tian, S. Pasca, J.
Ou, A. Krawisz, J. BernsteinJon, J. Rapoport, J. Hallmayer,
S. Horvath, M. Pellegrini, R. Dolmetsch, D. Geschwind,
ACE Genetics Consortium.